Selective chemokine and receptor gene expressions in allografts that develop transplant vasculopathy

Libby, 2001, Chronic rejection, Immunity, 14, 387, 10.1016/S1074-7613(01)00119-4 Uretsky, 1987, Development of coronary artery disease in cardiac patients receiving immunosuppressive therapy with cyclosporin and prednisone, Circulation, 76, 827, 10.1161/01.CIR.76.4.827 Gallo, 1997, Causes of late failure after heart transplantation, J Heart Lung Transplant, 16, 1113 Hosenpud, 2000, The Registry of the International Society for Heart and Lung Transplantation, J Heart Lung Transplant, 19, 909, 10.1016/S1053-2498(00)00138-8 Costanzo, 1998, Heart transplant coronary artery disease detected by coronary angiography, J Heart Lung Transplant, 17, 744 Gao, 1988, Accelerated coronary vascular disease in the heart transplantation patient, J Am Coll Cardiol, 12, 334, 10.1016/0735-1097(88)90402-0 St Goar, 1992, Intracoronary ultrasound in cardiac transplant recipients; in vivo evidence of “angiographically silent” intimal thickening, Circulation, 85, 979, 10.1161/01.CIR.85.3.979 Strehlau, 1997, Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation, Proc Natl Acad Sci U S A, 94, 695, 10.1073/pnas.94.2.695 Tullius, 1995, Both alloantigen-dependent and -independent factors influence chronic allograft rejection, Transplantation, 59, 313, 10.1097/00007890-199502150-00001 Wanders, 1995, Ischemia-induced transplant arteriosclerosis in the rat, Arterioscler Thromb Vasc Biol, 15, 145, 10.1161/ATVB.15v01.0145 Tori, 2000, Initial T-cell activation required for transplant vasculopathy in retransplanted rat cardiac allografts, Transplantation, 70, 737, 10.1097/00007890-200009150-00005 Shimizu, 2001, Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy, Nat Med, 7, 738, 10.1038/89121 Saiura, 2001, Circulating smooth muscle progenitor cells contribute to atherosclerosis, Nat Med, 7, 382, 10.1038/86394 Hillbrands, 2000, Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis, J Heart Lung Transplant, 19, 1183, 10.1016/S1053-2498(00)00209-6 Russell, 1995, Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection, Transplantation, 59, 572, 10.1097/00007890-199559040-00023 Nadeau, 1995, Sequential cytokine dynamics in chronic rejection of rat renal allografts, Proc Natl Acad Sci U S A, 92, 8729, 10.1073/pnas.92.19.8729 Mackay, 2001, Chemokines, Nat Immunol, 2, 95, 10.1038/84298 Gerard, 2001, Chemokines and disease, Nat Immunol, 2, 108, 10.1038/84209 Nelson, 2001, Chemokines, chemokine receptors, and allograft rejection, Immunity, 14, 377, 10.1016/S1074-7613(01)00118-2 Zlotnik, 2000, Chemokines. A new classification system and their role in immunity, Immunity, 12, 121, 10.1016/S1074-7613(00)80165-X Izikson, 2000, Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR) 2, J Exp Med, 192, 1075, 10.1084/jem.192.7.1075 Boring, 1998, Decreased lesion formation in CCR2-/- mice reveals a role for chemokine in the initiation of atherosclerosis, Nature, 394, 894, 10.1038/29788 Muller, 2001, Involvement of chemokine receptors in breast cancer metastasis, Nature, 410, 50, 10.1038/35065016 Gao, 2000, Targeting of the chemokine receptor, CCR1, suppresses development of acute and chronic cardiac allograft rejection, J Clin Invest, 105, 35, 10.1172/JCI8126 Hancock, 2000, Requirements of the chemokine receptor CXCR3 for acute allograft rejection, J Exp Med, 192, 1515, 10.1084/jem.192.10.1515 Agostin, 2001, CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection, Am J Pathol, 158, 1703, 10.1016/S0002-9440(10)64126-0 Izutani, 1995, Evidence that graft coronary arteriosclerosis begins in the early phase after transplantation and progresses without chronic immunoreaction. Histopathological analysis using a retransplantation model, Transplantation, 60, 1073, 10.1097/00007890-199511270-00002 Kitagawa-Sakakida, 2000, Active cell migration in retransplanted rat cardiac allografts during the course of chronic rejection, J Heart Lung Transplant, 19, 584, 10.1016/S1053-2498(00)00105-4 Mennander, 1991, Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis, Arterioscler Thromb, 11, 671, 10.1161/01.ATV.11.3.671 Lurie, 1981, Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model, Transplantation, 31, 41, 10.1097/00007890-198101000-00010 Adams, 1993, Experimental graft arteriosclerosis, Transplantation, 56, 794, 10.1097/00007890-199310000-00004 Isik, 1992, Transplant arteriosclerosis in a rat aortic model, Am J Pathology, 141, 1139 Mennander, 1996, Reversibility of allograft arteriosclerosis after retransplantation to donor strain, Transplantation, 62, 526, 10.1097/00007890-199608270-00016 Schmid, 1996, Retransplantation reverses mononuclear infiltration but not myointimal proliferation in a rat model of chronic cardiac allograft rejection, Transplantation, 61, 1695, 10.1097/00007890-199606270-00005 Kapoor, 2000, Early expression of interferon-γ inducible protein 10 and monokine induced by interferon-γ in cardiac allografts is mediated by CD8+ T cells, Transplantation, 69, 1147, 10.1097/00007890-200003270-00020 Hancock, 2001, Donor-derived IP-10 initiates development of acute allograft rejection, J Exp Med, 193, 975, 10.1084/jem.193.8.975 Yun, 2000, Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy, Transplantation, 69, 2515, 10.1097/00007890-200006270-00009 Fischereder, 2001, CC chemokine receptor 5 and renal-transplant survival, Lancet, 357, 1758, 10.1016/S0140-6736(00)04898-4